Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9604 posts found.

Novel Drug Movers and Shakers 2013-2016

June 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

To view the original whitepaper from NDA, please click here.Small and Medium Sized Companies in North America Lead Novel Drug …
News
Press release

Recipharm opens new GMP suite for clinical trial material

June 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM) …
News
Press release
europe-1395916_640

New game, new rules: Pathways for better and affordable medicines in Europe

June 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, market access

Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines at the European Public Health Alliance (EPHA), discusses the latest …
Feature

BMS’ Opdivo scores eighth approval in Europe for bladder cancer

June 5, 2017 Research and Development, Sales and Marketing Bristol-Myers Squibb, Cancer, Europe, European Commission, bladder cancer, immunotherapy

Bristol-Myers Squibb has announced that its flagship immunotherapy treatment Opdivo (nivolumab) has secured its eighth approval in Europe as the …
News
aging_-_hand

Latest prostate cancer research could provide boost for J&J

June 5, 2017 Research and Development, Sales and Marketing CRUK, Cancer, Johnson & Johnson, prostate cancer

Research funded by Cancer Research UK has found that abiraterone added to hormone therapy improved survival by over a third …
News
shutterstock_187433765

New targeted therapy promises strong response rate across 17 cancer types

June 5, 2017 Research and Development, Sales and Marketing ASCO, Cancer, Loxo Oncology, oncology

Loxo Oncology’s lead therapy larotrectinib made a big impact at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, …
News
ovarian_cancer

Breakthrough treatment for ovarian cancer displays promising results

June 5, 2017 Research and Development, Sales and Marketing Amgen, Cancer, ICR, ovarian cancer

A treatment that specifically targets ovarian cancer cells has shown that half of women who took the drug experienced shrinking …
News

Tau pathology as the key to understanding Alzheimer’s disease

June 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common type of dementia (60–70%)[1], causing problems with memory, language, …
Feature
White paper
abbvie_uk_france

Abbvie names new General Managers for UK and France

June 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, appointment

Abbvie has announced a double appointment across its UK and French operations, naming Jérôme Bouyer as its UK General Manager, …
Appointment
aedes_aegypti_mosquito

Research provides clues about Zika virus damage to foetal brains

June 2, 2017 Research and Development India, Zika, Zika virus

The Zika virus has been documented since 1947 and was first discovered to have infected a human in 1952. The …
News
sara_rajeswaran_v2

ABPI appoints new Executive Director of Government Affairs

June 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI

The ABPI has moved to appoint Saratha Rajeswaran to the position of Executive Director of Government Affairs and Devolved Nations. …
Appointment
astrazeneca_sign_sky

AZ’s Lynparza improves survival and maintains quality of life against ovarian cancer

June 2, 2017 Medical Communications, Research and Development AstraZeneca, lynparza

New Phase 3 trial data has found that AstraZeneca’s Lynparza (olaparib) provides sustained quality of life (QoL) and improved progression-free …
News
A example of a myelinated neuron

Old antibiotic offers potential cost-effective MS treatment

June 2, 2017 Medical Communications, Research and Development Myelin, multiple sclerosis

The cost of treatment for multiple sclerosis varies wildly, in the UK treatment can cost £56,000 per year while in …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday again, and the past week was populated with a host of riveting news and features from the life …
News

Clinical Trial Success: How Relationships Are Key

June 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing contract research organisations, cros

Jeffrey Zucker, Vice President of Feasibility and Recruitment Optimisation at Worldwide Clinical Trials, offers strategies for establishing and maintaining key …
Feature
White paper
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026